Mirion Technologies, Inc. (NYSE:MIR) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Mirion Technologies, Inc. (NYSE:MIR) have been assigned an average rating of “Moderate Buy” from the ten research firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $27.25.

A number of analysts recently commented on MIR shares. Melius Research upgraded shares of Mirion Technologies to a “strong-buy” rating in a research note on Monday, March 23rd. JPMorgan Chase & Co. decreased their price target on shares of Mirion Technologies from $30.00 to $27.00 and set an “overweight” rating for the company in a report on Thursday. Morgan Stanley lowered their price objective on shares of Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 11th. The Goldman Sachs Group dropped their price objective on shares of Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, February 12th. Finally, Citigroup cut their target price on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th.

Mirion Technologies Trading Down 1.7%

Mirion Technologies stock opened at $17.94 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.34 and a current ratio of 2.83. The stock has a market cap of $4.49 billion, a PE ratio of 163.07 and a beta of 0.99. The stock has a 50-day moving average of $22.17 and a two-hundred day moving average of $23.83. Mirion Technologies has a one year low of $12.00 and a one year high of $30.28.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). Mirion Technologies had a return on equity of 6.97% and a net margin of 3.11%.The business had revenue of $277.40 million for the quarter, compared to analysts’ expectations of $281.17 million. During the same quarter in the previous year, the firm posted $0.17 EPS. Mirion Technologies’s revenue was up 9.1% on a year-over-year basis. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. On average, research analysts anticipate that Mirion Technologies will post 0.39 EPS for the current fiscal year.

Institutional Trading of Mirion Technologies

Several large investors have recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans acquired a new position in Mirion Technologies in the 3rd quarter worth approximately $4,182,000. JPMorgan Chase & Co. raised its position in Mirion Technologies by 187.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 825,269 shares of the company’s stock worth $17,768,000 after buying an additional 537,900 shares during the last quarter. Rhumbline Advisers lifted its stake in Mirion Technologies by 91.1% during the 3rd quarter. Rhumbline Advisers now owns 608,834 shares of the company’s stock valued at $14,161,000 after acquiring an additional 290,232 shares during the period. Louisiana State Employees Retirement System purchased a new stake in shares of Mirion Technologies in the 3rd quarter valued at $2,438,000. Finally, New York State Teachers Retirement System purchased a new stake in shares of Mirion Technologies in the 3rd quarter valued at $1,269,000. Hedge funds and other institutional investors own 78.51% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.